Double-blind, placebo-controlled study to assess safety and efficacy of riluzole as a neuroprotective drug in patients with early, untreated Parkinson's disease

被引：0
|
作者：
Hunter, C
Jankovic, J
机构：
来源：
NEUROLOGY | 1999年 / 52卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A214 / A215
页数：2
相关论文
共 50 条
  • [41] A randomized, double-blind, placebo-controlled study of atornoxetine for freezing of gait in Parkinson's disease
    Nashatizadeh, M. M.
    Jimenez, J. E.
    Davidson, A. L.
    Jankovic, J.
    MOVEMENT DISORDERS, 2008, 23 (01) : S219 - S219
  • [42] Atomoxetine for the treatment of depression in Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Weintraub, D.
    Mavandadi, S.
    Horn, S.
    Hurtig, H.
    Siderowf, A.
    Duda, J.
    Stern, M.
    MOVEMENT DISORDERS, 2009, 24 : S286 - S286
  • [43] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF GEVOKIZUMAB IN THE TREATMENT OF GIANT CELL ARTERITIS
    Dasgupta, Bhaskar
    RHEUMATOLOGY, 2014, 53 : 7 - 7
  • [44] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF DOXERCALCIFEROL IN VITAMIN D-REPLETE CKD PATIENTS
    Patel, Anita
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : A60 - A60
  • [45] Transdermal Rotigotine in Early Stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Trial
    Mizuno, Yoshikuni
    Nomoto, Masahiro
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2013, 28 (10) : 1447 - 1450
  • [46] A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActiveTM) for COVID-19 Patients
    Majeed, Muhammed
    Nagabhushanam, Kalyanam
    Shah, Kalpesh
    Mundkur, Lakshmi
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
  • [47] A Randomized, Double-Blind, Placebo-Controlled Trial of Safinamide as Add-on Therapy in Early Parkinson's Disease Patients
    Stocchi, Fabrizio
    Borgohain, Rupam
    Onofrj, Marco
    Schapira, Anthony H. V.
    Bhatt, Mohit
    Lucini, Valentina
    Giuliani, Rodolfo
    Anand, Ravi
    MOVEMENT DISORDERS, 2012, 27 (01) : 106 - 112
  • [48] A 2-year, multicenter, placebo-controlled, double-blind, parallel-group study of the effect of riluzole on Parkinson's disease progression
    Rascol, O
    Olanow, W
    Brooks, D
    Koch, G
    Truffinet, P
    Bejuit, R
    MOVEMENT DISORDERS, 2002, 17 : S39 - S39
  • [49] MODERATO, a randomized, double-blind, placebo-controlled study to assess the effect of rasagiline on mild cognitive impairment in patients with Parkinson's disease: An ongoing study
    Choudhry, A.
    Weintraub, D.
    Hauser, R. A.
    MOVEMENT DISORDERS, 2014, 29 : S231 - S231
  • [50] Double-blind placebo-controlled study of velnacrine in Alzheimer's disease
    Zemlan, FP
    Keys, M
    Richter, RW
    Strub, RL
    LIFE SCIENCES, 1996, 58 (21) : 1823 - 1832
12345